ASX fintechs could ride Airwallex tailwind
Airwallex’s latest mega-raise shows there’s still big potential in Aussie fintech for investors paying attention.
Stockhead
REITs emerge as interest rate winners
With the Reserve Bank this week reducing interest rates and flagging more cuts, real estate investment trusts (REITs) will be among the biggest ASX beneficiaries.
A mining boom may not be too far away
Rising institutional interest in developers, a surge in gold and cash takeovers show the mining cycle may be ticking back towards a boom.
Locksley puts boots on ground at Mojave
Locksley Resources has mobilised its exploration team to the Mojave project ahead of expected approvals for antimony and rare earths drilling.
More Stories
Everything you need to know before the ASX opens
Good morning! Here’s everything you need to know, and some things you don’t, before the ASX flings open its doors and begins trading today.
The consequences of stockpiles
Western governments are ramping up calls to stockpile critical minerals. Will that provide the demand shock markets need, or just volatility?
Break it Down: Codrus Minerals
Tylah Tully looks at Codrus Minerals and its go ahead to start drilling at a previously producing gold project in the US state of Oregon.
StockTake: Greenvale Energy
Greenvale Energy has teamed up with Monash University once again to carry out test production of bitumen products.
Break it Down: Arika Resources
Arika Resources has raised $5 million to fund its gold drilling at the Yundamindra and Kookynie projects in Western Australia.
Why the US dollar is likely to keep falling in 2025
The US dollar has long been the undisputed anchor of the global financial system. But in 2025, it increasingly appears that the tide is turning.
TKM in quest for gold at Christmas Creek
Trek Metals has awarded a drilling contract and secured EIS funding to start drilling this month at Christmas Creek gold project in WA.
CDR unlocks power for fintech lenders
CDR hands the power to consumers over their financial data.
April’s top stocks
Australia’s S&P/ASX 200 rallied 3.62% in April, with African gallium explorer DY6 Metals winning top performing stock.
RAC doses first patient in solid tumour RC220 trial
Race Oncology has begun dosing patients in a Phase 1 clinical trial assessing RC220 in solid tumours
Original URL: https://www.goldcoastbulletin.com.au/business/stockhead/page/61